Brenton L. Saunders
2017
In 2017, Brenton L. Saunders earned a total compensation of $32.8M as Chairman, President and Chief Executive Officer at Allergan, a 693% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $249 |
|---|---|
| Non-Equity Incentive Plan | $8,752,500 |
| Salary | $1,232,822 |
| Stock Awards | $22,682,025 |
| Other | $160,030 |
| Total | $32,827,626 |
Saunders received $22.7M in stock awards, accounting for 69% of the total pay in 2017.
Saunders also received $249 of change in pension value and nonqualified deferred compensation earnings, $8.8M in non-equity incentive plan, $1.2M in salary and $160K in other compensation.
Rankings
In 2017, Brenton L. Saunders' compensation ranked 54th out of 14,666 executives tracked by ExecPay. In other words, Saunders earned more than 99.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 54 out of 14,666 | 100th |
Division Manufacturing | 10 out of 5,772 | 100th |
Major group Chemicals And Allied Products | 3 out of 2,075 | 100th |
Industry group Drugs | 3 out of 1,731 | 100th |
Industry Pharmaceutical Preparations | 3 out of 1,333 | 100th |
Source: SEC filing on March 23, 2018.
Saunders' colleagues
We found four more compensation records of executives who worked with Brenton L. Saunders at Allergan in 2017.